Cell Isolation Market Research Report - Global Forecast till 2027

Global Cell Isolation Market: Information By Product (Consumables and Instruments), Cell Type (Human Cells and Animal Cells), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation and Filtration-Based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics and Therapeutics), By End User (Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies, Cell Banks and Hospitals and Diagnostic Laboratories) - Forecast till 2027

ID: MRFR/LS/4734-CR | July, 2019 | Region : Global

Market Overview


According to MRFR, the Global Cell Isolation Market is poised to mature at a CAGR of 17.1% and acquire a value of USD 10.56 Billion during the review period of 2018 to 2023. The need for cell isolation is expected to rise with the rising prevalence of cancer and infectious diseases. 


COVID-19 Analysis


COVID-19 is an infectious disease caused by a new coronavirus that was most recently discovered. COVID-19 moved from a localised crisis to a global pandemic in only a few weeks, mostly unknown until the outbreak began in Wuhan (China) in December 2019. Although the COVID-19 pandemic tends to transform the development of multiple sectors, the immediate effect of the epidemic varies. While a decline in demand has been reported by a few sectors, many others will continue to remain unscathed and display exciting prospects for growth.


Market Dynamics


Drivers


Growing cancer prevalence, the government support for cell-based research, and technical advances are key factors for the development of the demand for cell isolation. Market development is driven by the increasing number of cancer and infectious disease patients, expanded federal support for cell-based research, a growing emphasis on precision medicine, and developments in technology. Another big factor driving the growth of the market is the growing need for customised medicine. Personalized care is a form of psychiatric therapy in which a particular patient is tailored for the procedure. In personalised medicine, cell separation methods may be used for early diagnosis of illness, allocation of suitable medication and assessment of therapeutic prognosis.


Opportunities


Increasing R&D Activities In The Pharmaceutical Sector Creates Growth Avenues for Key Players


To explain their biology and create novel cell therapies and other cell-based approaches, researchers use isolated cells. Due to its significance, numerous government bodies around the globe have expanded their funding for the growth of such research activities. In the past two years, support has risen dramatically for the development of cell therapies. In exchange, this increases the market for supplies, media, reagents, and accessories used in research into cell isolation. The use of many advanced equipment and methodologies is projected to grow in developing economies with the goal of rising competitiveness due to the increasing R&D activities in the pharmaceutical and biotechnology industries.


Restraints


High Cost Of Cell Isolation Systems To Impede Market Growth


On the other hand, during the projected timeframe, the high cost of cell isolation systems, complex cell behavioural features, and ethical concerns related to embryonic stem cell isolation are likely to hamper market development. The cost of study in cell biology is high because of the need to uphold high quality standards and comply with the requirements set out by regulatory authorities. Furthermore, the cell-based research success rate is very limited, and most cell therapy trials have a low success rate. Owing to financial limitations, it is impossible for numerous organisations and small-scale enterprises to buy luxury goods. As a consequence, in these countries, the use of automated kits and instruments is limited. This is one of the key reasons limiting the development of the market for cell isolation equipment.


Segmental Analysis


Global Cell Isolation Market is segmented on the basis of Product, Cell Type, Technique, Application, End-User, and Region. 


By Product


With a market valuation of USD 2343.3 million in 2017, consumables account for the largest share of the overall market and are forecast to reach a CAGR of 17.5 percent over the evaluation period.


By Cell Type


Owing to the rising cancer incidence that has prompted a heavy emphasis on cancer research and human stem cell therapy, the human cell type segment has the largest share of the overall market. At a CAGR of 17.4 percent during the forecast period, the human cell type segment is expected to show good growth.


By Technique


At present, owing to the widespread use of this technique in university and research labs, the largest section is centrifugation-based cell isolation. Its widespread use, as opposed to other segments, is due to its affordability. Over the analysis period, centrifugation-based cell isolation is predicted to display a CAGR of 17.3 percent.


By Application


Due to the growing interest in biologics, investment in biotechnology, the prevalence of chronic diseases and the increasing need for highly efficient therapeutic solutions that stand up to the resistance of drug molecules, the biomolecules isolation segment accounts for the most important share of the overall market. In the meantime, the cancer research segment is increasingly rising and a CAGR of 17.6 percent is projected to be achieved during the forecast period due to the increasing recognition of cancer and the participation of different government health agencies in the funding of cancer research.


By End-User


Owing to the usage of cell-based assays in the diagnosis of different diseases, the growing emphasis on biotechnology in the face of increasing cancer incidences and the increasing market for monoclonal antibodies & FABs as cancer therapies, biotechnology and biopharmaceutical companies are expected to report a CAGR of 17.7 percent during the study period.


Regional Analysis


The geographical overview of the global market has been conducted in four major regions, including the Asia Pacific, North America, Europe, and the rest of the world.


North America to Witness the Highest Growth


The Americas is expected to dominate the cell isolation market. The increase in the patient pool for chronic diseases, government funding for cancer research and presence of strong market players like Thermo Fisher Scientific drive the market growth in this regionThe regional market is driven by the growing need for viable care alternatives. In addition, the country is technologically innovative and there are substantially developed healthcare industries in emerging countries in the region that are at the forefront of cutting-edge science and technology. Driven by the U.S., America currently accounts for the highest share of the overall market.


Growing Presence of Major Players to Lead APAC Market


Meanwhile, during the evaluation period, Asia Pacific is forecast to rise at a robust CAGR of 17.7 percent. Asia Pacific is projected to see rapid growth in the demand for cell isolation due to rising cancer incidence and increased spending on health. Compared to other countries, the emergence of a wide demographic with a substantial customer base and the current reforms launched by the government in an attempt to change the healthcare system are projected to drive the industry..


Competitive Landscape



  • Beckman Coulter (U.S.)

  • Becton, Dickinson and Company (U.S.)

  • GE Healthcare (U.K.)

  • Merck KGaA (U.S.)

  • Miltenyi Biotec (Germany)

  • pluriSelect (Germany)

  • STEMCELL Technologies Inc. (Canada)

  • Terumo BCT (U.S.)

  • Thermo Fisher Scientific, Inc. (U.S.)


Recent Development


December 2020: Applied Cells, Inc. today revealed that the organisation has launched its Early Access Program MARS Bar System, a groundbreaking fully integrated high-capacity closed system for cell processing.


Report Overview


By Product



  • Consumables

  • Instruments


By Cell Type



  • Human Cells

  • Animal Cells


By Technique



  • Centrifugation-Based Cell Isolation

  • Surface Marker-Based Cell Isolation

  • Filtration-Based Cell Isolation


By Application



  • Biomolecule Isolation

  • Cancer Research

  • Stem Cell Research

  • Tissue Regeneration

  • In Vitro Diagnostics

  • Therapeutics


By End-User



  • Research Laboratories and Institutes

  • Biotechnology and Biopharmaceutical Companies

  • Cell Banks

  • Hospitals and Diagnostic Laboratories

The global cell isolation market is expected to experience a CAGR of 17.1% during the forecast period of 2018 to 2023. Cell isolation has grown considerably since its emergence and demand for it is increasing due to various factors including the growing demand for personalized medicine, increasing prevalence of chronic diseases and the increasing focus on technological advancements in cell isolation devices. Valued at USD 4,098.5 Mn in 2017, the global market is expected to reach an estimated USD 10,567.4 Mn by the end of 2023.


Cell isolation is a cost-effective method which is used for the isolation of cancer cells from biopsy samples. Once isolated by the relevant instruments, the cancer cells can be used for numerous applications including biomarker identification, microarray hybridization, and genetic analysis. The growing occurrences of cancer and infectious diseases are expected to increase the demand for cell isolation. For instance, in 2014, the Centers for Disease Control and Prevention recorded 9,421 new cases of tuberculosis that were registered in the US. Moreover, according to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the US. The rising occurrence of these diseases has further prompted government health authorities and major market players to increase investment in cell isolation to meet the growing demand for cell isolation instruments.


Although cell isolation is a cost-effective process, the instruments used are highly expensive. For instance, as of 2016, the chromium Single Cell Isolation system co-developed by Bio-Rad Laboratories and Illumina costs 50,000 USD. These associated costs act as market restraints. However, the increasing interest and investment in biotechnology are expected to develop affordable instruments in the coming years. Additionally, Cell isolation is finding a novel application in microfluidics where it is used for the development of drug assays. This application is yet to be explored to its full potential, thus leading the market toward expansion in the foreseeable future.


The global cell isolation market is segmented on the basis of product, cell type, technique, application, end-user, and region.  By product, the market is segmented into consumables and instruments. Consumables account for the largest share of the total market with a market value of USD 2343.3 million in 2017 and are expected to achieve a CAGR of 17.5% during the assessment period.


By cell type, the market is segmented into human cells and animal cells. The human cell type segment has the largest share of the total market due to the increasing prevalence of cancer which has driven a strong focus on cancer research and human stem cell therapy. The human cell type segment is expected to exhibit sturdy growth at a CAGR of 17.4% during the forecast period.


By technique, the market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. At present, the largest segment is centrifugation-based cell isolation due to the extensive use of this technique in academic and research laboratories. Its common use is owing to its affordability as compared to other segments. Centrifugation-based cell isolation is expected to witness a CAGR of 17.3% during the review period.


By application, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in-vitro diagnostics, and therapeutics. The biomolecules isolation segment accounts for the most significant share of the total market due to the increasing interest in biologics, investment in biotechnology, the prevalence of chronic diseases and the increasing demand for highly effective treatment options that stand up to the resistance of drug molecules. Meanwhile, the cancer research segment is growing rapidly and is expected to achieve a CAGR of 17.6% during the forecast period due to the increasing awareness surrounding cancer and the involvement of various government health authorities for the funding of cancer research.


By end-user, the market is segmented into research laboratories & institutes, biotechnology & biopharmaceutical companies, cell banks, and hospitals & diagnostic laboratories. Biotechnology and biopharmaceutical companies are expected to register a CAGR of 17.7% through the study period due to the use of cell-based assays in the diagnosis of various diseases, the increasing focus on biotechnology in the face of increasing incidences of cancer and the increasing demand for monoclonal antibodies & FABs as cancer therapeutics.


Regional Analysis


Led by the U.S, the Americas account for the largest share of the total market at present. The increasing prevalence of chronic diseases, rising expenses in R&D activities conducted by healthcare organizations and government bodies and the increasing demand for appropriate treatment options are driving the regional market. Moreover, the region is technologically advanced and developing countries in the region possess significantly developed healthcare sectors which are at the forefront of cutting-edge research and technology.


Meanwhile, the Asia Pacific is expected to grow at a robust CAGR of 17.7% during the assessment period. The presence of a massive population with a significant patient pool as compared to other regions and the ongoing initiatives introduced by the government in an effort to reform the healthcare sector is expected to drive the market. Countries such as Singapore, Australia, Malaysia, China, and India are the most lucrative markets in the region and have large patient pools, high amount of geriatric population and rapidly improving healthcare facilities. The market is restrained by the lack of appropriate capital, among other factors. However, a supportive regulatory framework regarding research of biotechnology is expected to boost market growth.


Competitive Tracking


Prominent players participating in the global cell isolation market include GE Healthcare, Becton, Dickinson & Company, Beckman Coulter, Thermo Fisher Scientific Inc., and Merck KGaA. Other players of note include TERUMO Corporation, Bio-Rad Laboratories, Miltenyi Biotec, STEMCELL Technologies, F.Hoffman-La Roche AG, and others. Research and Development are the key market strategies utilized by these players to compel further growth for the market.

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 20

3.2 Scope Of The Study 20

3.3 List Of Assumptions 20

3.4 Market Structure 21

4 Research Methodology

4.1 Research Process 23

4.2 Primary Research 24

4.3 Secondary Research 25

4.4 Market Size Estimation 26

4.5 Forecast Model 26

5 Market Dynamics

5.1 Introduction 28

5.2 Drivers 29

5.2.1 Rising Government Funding For Cell-Based Research 29

5.2.2 Increasing Prevalence Of Cancer And Infectious Diseases 29

5.2.3 Growing Technological Advancements In Cell Isolation Devices 29

5.2.4 Growing Demand For Personalized Medicine 29

5.3 Restraints 30

5.3.1 High Cost Of Cell Isolation Systems 30

5.3.2 Ethical Issues In Stem Cell Isolation 30

5.4 Opportunities 30

5.4.1 Growing Stem Cell Research 30

5.4.2 Application Of Cell Isolation In Microfluidics 30

5.5 Challenges 30

5.5.1 Overcoming Limitations Of The Available Cell Isolation Technologies 30

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 33

6.1.1 Bargaining Power Of Suppliers 33

6.1.2 Bargaining Power Of Buyers 34

6.1.3 Threat Of New Entrants 34

6.1.4 Threat Of Substitutes 34

6.1.5 Intensity Of Rivalry 34

6.2 Value Chain Analysis 35

6.2.1 R&D And Designing 35

6.2.2 Manufacturing 35

6.2.3 Distribution & Sales 35

6.2.4 Post-Sales Services 36

7 Cell Isolation Market, By Product

7.1 Overview 38

7.2 Consumables 39

7.2.1 Reagents, Kits, Media, And Sera 39

7.2.2 Beads 39

7.2.3 Disposables 40

7.3 Instruments 40

7.3.1 Centrifuges 40

7.3.2 Flow Cytometers 41

7.3.3 Magnetic-Activated Cell Separator Systems 41

7.3.4 Filtration Systems 41

8 Cell Isolation Market, By Cell Type

8.1 Overview 44

8.2 Human Cells 45

8.3 Animal Cells 45

9 Cell Isolation Market, By Technique

9.1 Overview 47

9.2 Centrifugation-Based Cell Isolation 48

9.3 Surface Marker-Based Cell Isolation 48

9.4 Filtration-Based Cell Isolation 49

10 Cell Isolation Market, By Application

10.1 Overview 51

10.2 Biomolecule Isolation 52

10.3 Cancer Research 52

10.4 Stem Cell Research 53

10.5 Tissue Regeneration 53

10.6 In Vitro Diagnostics 53

10.7 Therapeutics 55

11 Cell Isolation Market, By End User

11.1 Overview 57

11.2 Research Laboratories And Institutes 59

11.3 Biotechnology And Biopharmaceutical Companies 59

11.4 Cell Banks 59

11.5 Hospitals And Diagnostic Laboratories 60

12 Global Cell Isolation Market, By Region

12.1 Overview 62

12.2 Americas 63

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.2.1 North America 66

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.2.1.1 U.S. 69

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.2.1.2 Canada 71

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.2.2 South America 74

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3 Europe 77

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.1 Western Europe 80

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.1.1 Germany 83

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.1.2 France 85

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.1.3 U.K. 88

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.1.4 Italy 90

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.1.5 Spain 93

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.1.6 Rest Of Western Europe 95

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.3.2 Eastern Europe 98

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.4 Asia Pacific 101

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.4.1 Japan 104

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.4.2 China 106

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.4.3 India 109

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.4.4 Australia 111

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.4.5 Republic Of Korea 114

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.4.6 Rest Of Asia Pacific 116

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.5 The Middle East And Africa 119

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.5.1 Middle East 122

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

12.5.2 Africa 124

Cell Isolation Market, By Product

Cell Isolation Market, By Cell Type

Cell Isolation Market, By Technique

Cell Isolation Market, By Application

Cell Isolation Market, By End User

13 Competitive Landscape

13.1 Introduction 128

13.2 Company Share Analysis 128

14 Company Profiles

14.1 GE HEALTHCARE 130

14.1.1 Company Overview 130

14.1.2 Financial Overview 130

14.1.3 Products Offering 131

14.1.4 Key Developments 131

14.1.5 SWOT Analysis 131

14.1.6 Key Strategy 131

14.2 STEMCELL Technologies 132

14.2.1 Company Overview 132

14.2.2 Financial Overview 132

14.2.3 Products Offering 132

14.2.4 Key Developments 132

14.2.5 SWOT Analysis 133

14.2.6 Key Strategy 133

14.3 Becton, Dickinson And Company 134

14.3.1 Company Overview 134

14.3.2 Financial Overview 134

14.3.3 Products Offering 135

14.3.4 Key Developments 135

14.3.5 SWOT Analysis 135

14.3.6 Key Strategy 135

14.4 Merck KGaA 136

14.4.1 Company Overview 136

14.4.2 Financial Overview 136

14.4.3 Products Offering 137

14.4.4 Key Developments 137

14.4.5 SWOT Analysis 137

14.4.6 Key Strategy 137

14.5 Thermo Fisher Scientific Inc. 138

14.5.1 Company Overview 138

14.5.2 Financial Overview 138

14.5.3 Products Offering 139

14.5.4 Key Developments 139

14.5.5 SWOT Analysis 139

14.5.6 Key Strategy 139

14.6 Bio-Rad Laboratories Inc 140

14.6.1 Company Overview 140

14.6.2 Financial Overview 140

14.6.3 Products Offering 142

14.6.4 Key Developments 142

14.6.5 SWOT Analysis 142

14.6.6 Key Strategy 142

14.7 TERUMO CORPORATION 143

14.7.2 Financial Overview 143

14.7.3 Products Offering 144

14.7.4 Key Developments 144

14.7.5 SWOT Analysis 144

14.7.6 Key Strategy 144

14.8 Beckman Coulter 145

14.8.1 Company Overview 145

14.8.2 Financial Overview 145

14.8.3 Products Offering 146

14.8.4 Key Developments 146

14.8.5 SWOT Analysis 146

14.8.6 Key Strategy 146

14.9 PluriSelect Life Science UG 147

14.9.1 Company Overview 147

14.9.2 Financial Overview 147

14.9.3 Products Offering 147

14.9.4 Key Developments 147

14.9.5 SWOT Analysis 148

14.9.6 Key Strategy 148

14.10 F. Hoffmann-La Roche AG 149

14.10.1 Company Overview 149

14.10.2 Financial Overview 149

14.10.3 Products Offering 150

14.10.4 Key Developments 150

14.10.5 SWOT Analysis 150

14.10.6 Key Strategy 150

14.11 Miltenyi Biotec 151

14.11.1 Company Overview 151

14.11.2 Financial Overview 151

14.11.3 Products Offering 151

14.11.4 Key Developments 151

14.11.5 SWOT Analysis 152

14.11.6 Key Strategy 152

14.12 Sartorius AG 153

14.12.2 Financial Overview 153

14.12.3 Products Offering 154

14.12.4 Key Developments 154

14.12.5 SWOT Analysis 154

14.12.6 Key Strategy 154

14.13 Cell Biolabs, Inc. 155

14.13.1 Company Overview 155

14.13.2 Financial Overview 155

14.13.3 Products Offering 155

14.13.4 Key Developments 155

14.13.5 SWOT Analysis 155

14.13.6 Key Strategy 155

15 Appendix

15.1 Discussion Blue Print 157

16 List Of Tables

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 LIST OF ASSUMPTIONS 20

TABLE 3 PRIMARY INTERVIEWS 23

TABLE 4 GLOBAL: CELL ISOLATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 36

TABLE 5 GLOBAL: CELL ISOLATION MARKET FOR CONSUMABLES BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 6 GLOBAL: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 7 GLOBAL: CELL ISOLATION MARKET FOR BEADS BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 8 GLOBAL: CELL ISOLATION MARKET FOR DISPOSABLES BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 9 GLOBAL: CELL ISOLATION MARKET FOR INSTRUMENTS BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 10 GLOBAL: CELL ISOLATION MARKET FOR CENTRIFUGES BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 11 GLOBAL: CELL ISOLATION MARKET FOR BEADS BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 12 GLOBAL: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS BY REGION,

2020 TO 2027 (USD MILLION) 39

TABLE 13 GLOBAL: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 14 GLOBAL: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 41

TABLE 15 GLOBAL: CELL ISOLATION MARKET FOR HUMAN CELLS BY REGION, 2020 TO 2027 (USD MILLION) 42

TABLE 16 GLOBAL: CELL ISOLATION MARKET FOR ANIMAL CELLS BY REGION, 2020 TO 2027 (USD MILLION) 42

TABLE 17 GLOBAL: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 44

TABLE 18 GLOBAL: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION BY REGION, 2020 TO 2027 (USD MILLION) 45

TABLE 19 GLOBAL: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION BY REGION, 2020 TO 2027 (USD MILLION) 45

TABLE 20 GLOBAL: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION BY REGION, 2020 TO 2027 (USD MILLION) 46

TABLE 21 GLOBAL: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 49

TABLE 22 GLOBAL: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION BY REGION, 2020 TO 2027 (USD MILLION) 49

TABLE 23 GLOBAL: CELL ISOLATION MARKET FOR CANCER RESEARCH BY REGION, 2020 TO 2027 (USD MILLION) 49

TABLE 24 GLOBAL: CELL ISOLATION MARKET FOR STEM CELL RESEARCH BY REGION, 2020 TO 2027 (USD MILLION) 50

TABLE 25 GLOBAL: CELL ISOLATION MARKET FOR TISSUE REGENERATION BY REGION, 2020 TO 2027 (USD MILLION) 50

TABLE 26 GLOBAL: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS BY REGION, 2020 TO 2027 (USD MILLION) 50

TABLE 27 GLOBAL: CELL ISOLATION MARKET FOR TISSUE REGENERATION BY REGION, 2020 TO 2027 (USD MILLION) 51

TABLE 28 GLOBAL: CELL ISOLATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 53

TABLE 29 GLOBAL: CELL ISOLATION MARKET FOR RESEARCH LABORATORIES AND INSTITUTES BY REGION,

2020 TO 2027 (USD MILLION) 54

TABLE 30 GLOBAL: CELL ISOLATION MARKET FOR BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES BY REGION,

2020 TO 2027 (USD MILLION) 54

TABLE 31 GLOBAL: CELL ISOLATION MARKET FOR CELL BANKS BY REGION, 2020 TO 2027 (USD MILLION) 54

TABLE 32 GLOBAL: CELL ISOLATION MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES BY REGION,

2020 TO 2027 (USD MILLION) 55

TABLE 33 GLOBAL: CELL ISOLATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 57

TABLE 34 AMERICAS: CELL ISOLATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 58

TABLE 35 AMERICAS: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 58

TABLE 36 AMERICAS: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 59

TABLE 37 AMERICAS: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 59

TABLE 38 AMERICAS: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 59

TABLE 39 AMERICAS: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 60

TABLE 40 AMERICAS: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 60

TABLE 41 AMERICAS: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 60

TABLE 42 NORTH AMERICA: CELL ISOLATION MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 61

TABLE 43 NORTH AMERICA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 61

TABLE 44 NORTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 45 NORTH AMERICA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 46 NORTH AMERICA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 47 NORTH AMERICA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 62

TABLE 48 NORTH AMERICA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 63

TABLE 49 NORTH AMERICA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 63

TABLE 50 U.S.: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 64

TABLE 51 U.S.: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 52 U.S.: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 53 U.S.: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 54 U.S.: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 65

TABLE 55 U.S.: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 65

TABLE 56 U.S.: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 66

TABLE 57 CANADA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 66

TABLE 58 CANADA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 59 CANADA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 60 CANADA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 61 CANADA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 67

TABLE 62 CANADA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 68

TABLE 63 CANADA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 68

TABLE 64 SOUTH AMERICA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 69

TABLE 65 SOUTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 66 SOUTH AMERICA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 67 SOUTH AMERICA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 70

TABLE 68 SOUTH AMERICA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 70

TABLE 69 SOUTH AMERICA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 70

TABLE 70 SOUTH AMERICA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 71

TABLE 71 EUROPE: CELL ISOLATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 72

TABLE 72 EUROPE: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 72

TABLE 73 EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 74 EUROPE: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 75 EUROPE: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 76 EUROPE: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 74

TABLE 77 EUROPE: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 74

TABLE 78 EUROPE: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 74

TABLE 79 WESTERN EUROPE: CELL ISOLATION MARKET BY COUNTRY/REGION, 2020 TO 2027 (USD MILLION) 75

TABLE 80 WESTERN EUROPE: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 75

TABLE 81 WESTERN EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 76

TABLE 82 WESTERN EUROPE: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 76

TABLE 83 WESTERN EUROPE: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 76

TABLE 84 WESTERN EUROPE: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 77

TABLE 85 WESTERN EUROPE: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 77

TABLE 86 WESTERN EUROPE: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 77

TABLE 87 GERMANY: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 78

TABLE 88 GERMANY: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 89 GERMANY: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 90 GERMANY: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 91 GERMANY: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 79

TABLE 92 GERMANY: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 79

TABLE 93 GERMANY: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 80

TABLE 94 FRANCE: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 80

TABLE 95 FRANCE: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 96 FRANCE: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 81

TABLE 97 FRANCE: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 81

TABLE 98 FRANCE: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 81

TABLE 99 FRANCE: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 82

TABLE 100 FRANCE: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 82

TABLE 101 U.K.: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 83

TABLE 102 U.K.: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 103 U.K.: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 104 U.K.: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 84

TABLE 105 U.K.: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 84

TABLE 106 U.K.: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 84

TABLE 107 U.K.: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 85

TABLE 108 ITALY: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 85

TABLE 109 ITALY: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 110 ITALY: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 86

TABLE 111 ITALY: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 86

TABLE 112 ITALY: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 86

TABLE 113 ITALY: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 87

TABLE 114 ITALY: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 87

TABLE 115 SPAIN: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 88

TABLE 116 SPAIN: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 117 SPAIN: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 118 SPAIN: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 89

TABLE 119 SPAIN: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 89

TABLE 120 SPAIN: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 89

TABLE 121 SPAIN: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 90

TABLE 122 REST OF WESTERN EUROPE: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 90

TABLE 123 REST OF WESTERN EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 90

TABLE 124 REST OF WESTERN EUROPE: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 125 REST OF WESTERN EUROPE: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 126 REST OF WESTERN EUROPE: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 91

TABLE 127 REST OF WESTERN EUROPE: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 92

TABLE 128 REST OF WESTERN EUROPE: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 92

TABLE 129 EASTERN EUROPE: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 93

TABLE 130 EASTERN EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 131 EASTERN EUROPE: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 132 EASTERN EUROPE: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 94

TABLE 133 EASTERN EUROPE: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 94

TABLE 134 EASTERN EUROPE: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 94

TABLE 135 EASTERN EUROPE: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 95

TABLE 136 ASIA-PACIFIC: CELL ISOLATION MARKET BY COUNTRY/REGION, 2020 TO 2027 (USD MILLION) 96

TABLE 137 ASIA-PACIFIC: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 96

TABLE 138 ASIA-PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 97

TABLE 139 ASIA-PACIFIC: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 97

TABLE 140 ASIA-PACIFIC: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 97

TABLE 141 ASIA-PACIFIC: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 98

TABLE 142 ASIA-PACIFIC: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 98

TABLE 143 ASIA-PACIFIC: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 98

TABLE 144 JAPAN: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 99

TABLE 145 JAPAN: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 99

TABLE 146 JAPAN: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 99

TABLE 147 JAPAN: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 100

TABLE 148 JAPAN: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 100

TABLE 149 JAPAN: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 100

TABLE 150 JAPAN: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 101

TABLE 151 CHINA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 101

TABLE 152 CHINA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 101

TABLE 153 CHINA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 102

TABLE 154 CHINA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 102

TABLE 155 CHINA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 102

TABLE 156 CHINA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 103

TABLE 157 CHINA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 103

TABLE 158 INDIA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 104

TABLE 159 INDIA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 104

TABLE 160 INDIA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 104

TABLE 161 INDIA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 105

TABLE 162 INDIA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 105

TABLE 163 INDIA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 105

TABLE 164 INDIA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 106

TABLE 165 AUSTRALIA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 106

TABLE 166 AUSTRALIA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 106

TABLE 167 AUSTRALIA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 107

TABLE 168 AUSTRALIA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 107

TABLE 169 AUSTRALIA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 107

TABLE 170 AUSTRALIA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 108

TABLE 171 AUSTRALIA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 108

TABLE 172 REPUBLIC OF KOREA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 109

TABLE 173 REPUBLIC OF KOREA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 109

TABLE 174 REPUBLIC OF KOREA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 109

TABLE 175 REPUBLIC OF KOREA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 110

TABLE 176 REPUBLIC OF KOREA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 110

TABLE 177 REPUBLIC OF KOREA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 110

TABLE 178 REPUBLIC OF KOREA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 111

TABLE 179 REST OF ASIA-PACIFIC: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 111

TABLE 180 REST OF ASIA-PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 111

TABLE 181 REST OF ASIA-PACIFIC: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 112

TABLE 182 REST OF ASIA-PACIFIC: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 112

TABLE 183 REST OF ASIA-PACIFIC: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 112

TABLE 184 REST OF ASIA-PACIFIC: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 113

TABLE 185 REST OF ASIA-PACIFIC: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 113

TABLE 186 THE MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 114

TABLE 187 THE MIDDLE EAST AND AFRICA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 114

TABLE 188 THE MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 115

TABLE 189 THE MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 115

TABLE 190 THE MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 115

TABLE 191 THE MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 116

TABLE 192 THE MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 116

TABLE 193 THE MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 116

TABLE 194 MIDDLE EAST: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 117

TABLE 195 MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 117

TABLE 196 MIDDLE EAST: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 117

TABLE 197 MIDDLE EAST: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 118

TABLE 198 MIDDLE EAST: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 118

TABLE 199 MIDDLE EAST: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 118

TABLE 200 MIDDLE EAST: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 119

TABLE 201 AFRICA: CELL ISOLATION BY PRODUCT, 2020 TO 2027 (USD MILLION) 119

TABLE 202 AFRICA: CELL ISOLATION MARKET FOR CONSUMABLES BY TYPE, 2020 TO 2027 (USD MILLION) 119

TABLE 203 AFRICA: CELL ISOLATION MARKET BY INSTRUMENTS BY TYPE, 2020 TO 2027 (USD MILLION) 120

TABLE 204 AFRICA: CELL ISOLATION MARKET BY CELL TYPE, 2020 TO 2027 (USD MILLION) 120

TABLE 205 AFRICA: CELL ISOLATION MARKET BY TECHNIQUE, 2020 TO 2027 (USD MILLION) 120

TABLE 206 AFRICA: CELL ISOLATION MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 121

TABLE 207 AFRICA: CELL ISOLATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 121

17 List Of Figures

FIGURE 1 GLOBAL: CELL ISOLATION MARKET: MARKET STRUCTURE 21

FIGURE 2 RESEARCH PROCESS OF MRFR 23

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 26

FIGURE 4 PORTER’S FIVE FORCES MODEL 32

FIGURE 5 VALUE CHAIN: CELL ISOLATION MARKET 34

FIGURE 6 GLOBAL: CELL ISOLATION BY PRODUCT, 2020 & 2027 (USD MILLION) 36

FIGURE 7 GLOBAL: CELL ISOLATION MARKET BY CELL TYPE, 2020 & 2027 (USD MILLION) 41

FIGURE 8 GLOBAL: CELL ISOLATION MARKET BY TECHNIQUE, 2020 & 2027 (USD MILLION) 44

FIGURE 9 GLOBAL: CELL ISOLATION MARKET BY APPLICATION, 2020 & 2027 (USD MILLION) 48

FIGURE 10 GLOBAL: CELL ISOLATION MARKET BY APPLICATION, 2020 & 2027 (USD MILLION) 53

FIGURE 11 GLOBAL: CELL ISOLATION MARKET BY REGION, 2020 & 2027 (USD MILLION) 57

FIGURE 12 AMERICAS: CELL ISOLATION MARKET SHARE BY COUNTRY, 2020 (%) 58

FIGURE 13 EUROPE: CELL ISOLATION MARKET SHARE BY REGION, 2020 (%) 72

FIGURE 14 WESTERN EUROPE: CELL ISOLATION MARKET SHARE BY COUNTRY/REGION, 2020 (%) 75

FIGURE 15 ASIA-PACIFIC: CELL ISOLATION MARKET SHARE BY COUNTRY/REGION, 2020 (%) 96

FIGURE 16 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET SHARE BY COUNTRY, 2020 (%) 114

FIGURE 17 GLOBAL: CELL ISOLATION MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 123

Cell Isolation Market

Global Cell Isolation Market: Competitive Landscape


The global cell isolation market is a huge market with a number of big market players operating in various regions across the world. These players have come up with innovative products that are being used for various applications such as cancer research, stem cell research, and many others. Some of the major players include Thermo Fisher Scientific Inc., GE Healthcare, Becton, Dickinson and Company, Beckman Coulter, Merck KGaA, STEMCELL Technologies, Miltenyi Biotec, TERUMO CORPORATION, Bio-Rad Laboratories Inc, and F. Hoffmann-La Roche AG. Apart from these, there is a large number of companies involved in the development of new products.


The global cell isolation market is currently dominated by Thermo Fisher Scientific Inc. with 11.8% of the total market share. Thermo Fisher Scientific with its technically magnificent products and skilled workforce is assisting its customers to accelerate life science research as well as to get better outcomes in challenging clinical research fields. Through their premier brands Thermo Scientific, Invitrogen, Fisher Scientific Applied Biosystems, and Unity Lab Services cater to several products such as analytical instruments, laboratory supply chain programs and e-commerce, laboratory equipment, lab services, specialty diagnostics, and others.


GE Healthcare has the second largest market share in the global cell isolation market. GE Healthcare held 10.5% of the total market in 2017. The company was founded in 2004. GE Healthcare is a unit of General Electric Company.GE healthcare is expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement, and performance solutions. It helps its customers to deliver better care and facilities around the world at low cost.


It collaborates with human services pioneers, endeavoring to influence the worldwide arrangement change that is important to actualize an effective move toward practical medicinal service frameworks.


GE Healthcare has generated massive revenues from the sales of healthcare. Besides these two, Becton, Dickinson and Company, Beckman Coulter, and Merck KGaA have secured third, fourth, and fifth positions with 9.6%, 7.9%, and 6.2% respectively of the market share.